RAD18 and cancer: Our structural elucidation of the MAGEA4 MHD-RAD18 R6BD complex has provided molecular evidence to clarify confusions caused by the AlphaFold2 modeling and accelerate the development of MAGEA4-RAD18 antagonists to dismantle a key enabling feature of cancer cells.